Society | Apr 22

Japan health ministry panel OKs 3rd COVID-19 treatment drug

Apr 22 (Kyodo) - A health ministry panel on Wednesday approved rheumatoid arthritis drug baricitinib for COVID-19 treatment, the third such case in Japan.

U.S. pharmaceutical group Eli Lilly and Co.'s Japan unit filed for approval in December. The Health, Labor and Welfare Ministry is expected to formally approve the drug within a month.

In the United States, baricitinib has been approved for use in combination with anti-viral drug remdesivir for coronavirus patients who need supplemental oxygen.


MORE Society NEWS

A former host admitted to knowingly receiving approximately 25 million yen that had been deceitfully obtained by convicted scammer "Riri-chan," in a trial held on April 23.

Osaka City has issued an administrative order to stop feeding pigeons and crows following continuous complaints about droppings and noise.

A cherry tree located at one of Kyoto's busiest pedestrian streets, Sanneizaka, a main pathway to Kiyomizu Temple, suddenly fell at 11:45 AM on Tuesday, trapping a school teacher beneath.

POPULAR NEWS

A private organization has revealed that approximately 40% of the national municipalities, totaling 744, could potentially disappear by 2050 due to declining populations.

Youngsters in Japan are enthusiastically embracing the world of cosmetics, with a recent survey reporting some 60% of elementary students own some form of makeup.

Major American IT companies like Microsoft and Oracle have announced substantial investments totalling 4 trillion yen ($26 billion) in data centers in Japan, sparking concerns about digital sovereignty and AI development.

A former host admitted to knowingly receiving approximately 25 million yen that had been deceitfully obtained by convicted scammer "Riri-chan," in a trial held on April 23.

A cherry tree located at one of Kyoto's busiest pedestrian streets, Sanneizaka, a main pathway to Kiyomizu Temple, suddenly fell at 11:45 AM on Tuesday, trapping a school teacher beneath.

FOLLOW US